Few opportunities exist in the Mid-South for students to gain first-hand experience of clinical and basic research in pediatric cancer. The proposed program in professional oncology education, to be conducted in a large, multidisciplinary pediatric cancer research and treatment center, is designed to meet that need. It will provide medical and allied health students with short rotations in one of the clinical or basic science disciplines emphasized at St. Jude Hospital. Educational methods will vary, depending on the subject matter covered and tutorial preferences of the instructors, but will uniformly include exposure to laboratory techniques and clinical procedures. literature and medical records review, attendance at institutional conferences, and experience in use of the scientific method. Students will be given ample time to interact with staff members in disciplines outside their planned rotation. Our goal is to stimulate interest in careers in cancer research and cancer patient management. Similar elective rotations that emphasize participation in clinical care of cancer patients are offered to pediatric residents whose programs do not provide adequate exposure to oncology. To assist practicing physicians, nurses and other health-care professionals in staying abreast of the rapid pace of cancer research findings and advances in cancer care for children. Attendees at symposia are asked to complete evaluations of the conferences. In the absence of research breakthroughs, the best chance to decrease the morbidity and mortality of cancer will come from improved education leading in prevention and earlier detection. Students who have been introduced to research in pediatric cancer may elect to pursue research careers. However, even if they do not engage in research, they will provide a base of knowledge within their communities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA023944-12
Application #
3451804
Study Section
Special Emphasis Panel (SRC (92))
Project Start
1978-07-01
Project End
1994-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Huang, I-Chan; Klosky, James L; Young, Chelsea M et al. (2018) Misclassification of self-reported smoking in adult survivors of childhood cancer. Pediatr Blood Cancer 65:e27240
Inaba, Hiroto; Cao, Xueyuan; Han, Alice Q et al. (2018) Bone mineral density in children with acute lymphoblastic leukemia. Cancer 124:1025-1035
Triplett, Brandon M; Muller, Brad; Kang, Guolian et al. (2018) Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion. Transpl Infect Dis 20:
Kaye, Erica C; Jerkins, Jonathan; Gushue, Courtney A et al. (2018) Predictors of Late Palliative Care Referral in Children With Cancer. J Pain Symptom Manage 55:1550-1556
Wang, Bo; Joo, Joung Hyuck; Mount, Rebecca et al. (2018) The COPII cargo adapter SEC24C is essential for neuronal homeostasis. J Clin Invest 128:3319-3332
Hanna, Jason A; Garcia, Matthew R; Lardennois, Alicia et al. (2018) PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene 37:1991-2007
Donohoe, Clare; Bosi, Judy K; Sykes, April et al. (2018) Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis. Oncol Nurs Forum 45:457-462
Lucas Jr, John T; Knapp, Brendan J; Uh, Jinsoo et al. (2018) Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib. Clin Neuroradiol 28:393-400
Tartey, Sarang; Gurung, Prajwal; Dasari, Tejasvi Krishna et al. (2018) ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis. J Clin Invest 128:2042-2047
Malireddi, R K Subbarao; Gurung, Prajwal; Mavuluri, Jayadev et al. (2018) TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med 215:1023-1034

Showing the most recent 10 out of 255 publications